Can one cell-line meet the demands of product quantities and varieties?

There is an industry need for new high performance technologies that achieve the goal of meeting the unmet needs of bio-manufacturing. These technologies must be: effective, safe, have decent capacity, rapid response, be cost-effective and simple to manufacture. Fraunhofer USA are attempting to produce these technologies. Pilot production has operated to USFDA cGMP standards. Should the technologies be biological- can …